A detailed history of Two Sigma Investments, LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 917,594 shares of IRWD stock, worth $3.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
917,594
Previous 1,188,233 22.78%
Holding current value
$3.69 Million
Previous $10.3 Million 42.2%
% of portfolio
0.01%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.58 - $8.61 $1.51 Million - $2.33 Million
-270,639 Reduced 22.78%
917,594 $5.98 Million
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $5.01 Million - $9.31 Million
602,386 Added 102.82%
1,188,233 $10.3 Million
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $7.11 Million - $9.3 Million
-808,316 Reduced 57.98%
585,847 $6.7 Million
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $10.4 Million - $14.2 Million
-1,255,487 Reduced 47.38%
1,394,163 $13.4 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $11.4 Million - $13.1 Million
1,125,429 Added 73.84%
2,649,650 $28.2 Million
Q1 2023

May 15, 2023

SELL
$10.37 - $12.56 $627,022 - $759,440
-60,465 Reduced 3.82%
1,524,221 $16 Million
Q4 2022

Feb 14, 2023

BUY
$9.9 - $12.43 $14 Million - $17.6 Million
1,418,429 Added 853.15%
1,584,686 $19.6 Million
Q3 2022

Nov 14, 2022

SELL
$10.14 - $12.38 $7.03 Million - $8.58 Million
-693,237 Reduced 80.66%
166,257 $1.72 Million
Q2 2022

Aug 15, 2022

SELL
$11.05 - $12.72 $324,803 - $373,891
-29,394 Reduced 3.31%
859,494 $9.91 Million
Q1 2022

May 16, 2022

BUY
$10.61 - $12.88 $9.43 Million - $11.4 Million
888,888 New
888,888 $11.2 Million
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $3.68 Million - $4.72 Million
-338,634 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $1.03 Million - $1.21 Million
86,718 Added 34.42%
338,634 $4.42 Million
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $2.13 Million - $2.75 Million
-209,671 Reduced 45.42%
251,916 $3.24 Million
Q1 2021

May 17, 2021

SELL
$9.04 - $11.86 $2.09 Million - $2.74 Million
-231,368 Reduced 33.39%
461,587 $5.16 Million
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $5.02 Million - $6.77 Million
554,689 Added 401.18%
692,955 $7.89 Million
Q3 2020

Nov 16, 2020

BUY
$8.99 - $10.74 $1.24 Million - $1.48 Million
138,266 New
138,266 $1.24 Million
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $2.39 Million - $3.13 Million
-261,449 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$8.58 - $14.01 $10.6 Million - $17.2 Million
-1,229,658 Reduced 82.47%
261,449 $2.64 Million
Q4 2019

Feb 14, 2020

BUY
$8.22 - $14.0 $8.18 Million - $13.9 Million
995,225 Added 200.7%
1,491,107 $19.8 Million
Q3 2019

Nov 14, 2019

BUY
$8.59 - $10.96 $2.31 Million - $2.95 Million
269,297 Added 118.85%
495,882 $4.26 Million
Q2 2019

Aug 14, 2019

SELL
$9.8 - $12.89 $6.19 Million - $8.14 Million
-631,326 Reduced 73.59%
226,585 $2.48 Million
Q1 2019

May 15, 2019

BUY
$8.27 - $12.73 $5.61 Million - $8.63 Million
678,224 Added 377.45%
857,911 $11.6 Million
Q4 2018

Feb 14, 2019

BUY
$7.8 - $16.13 $546,062 - $1.13 Million
70,008 Added 63.83%
179,687 $1.86 Million
Q3 2018

Nov 14, 2018

BUY
$14.31 - $17.65 $1.57 Million - $1.94 Million
109,679 New
109,679 $2.03 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $616M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.